Terumo Corporation Revises Earnings Guidance for the Year Ending March 31, 2022
August 04, 2021 at 02:00 am EDT
Share
Terumo Corporation revised earnings guidance for the year ending March 31, 2022. For the year, the company expects revenue of JPY 685,000 million compared to previous guidance is to be in the range of JPY 670,000 million to JPY 680,000 million, operating profit of JPY 120,000 million compared to previous guidance is to be in the range of JPY 107,000 million to JPY 113,000 million, profit for the year attributable to the owner of parent of JPY 92,000 million compared to previous guidance is to be in the range of JPY 82,000 million to JPY 86,500 million and earnings per share of JPY 121.69 compared to previous guidance is to be in the range of JPY 108.46 to JPY 114.42.
Terumo Corporation specializes in the design, manufacturing and marketing of medical products and equipments. Net sales break down by family of products as follows:
- cardiac surgery devices (53.5%);
- medical products for hospitals (28.6%): medical devices, nutritional additives, oxygen, medical measuring devices (thermometers, tensiometers, glucometers, etc.), etc.;
- sanguine transfusion equipments (17.9%).
Net sales break down geographically as follows: Japan (32.9%), America (29.5%), Europe (19.6%), China (7.4%) and other (10.6%).
TERUMO CORPORATION 
